Search results
Reveal Genomics launches HER2+ breast cancer diagnostics trial
Medical Device Network via Yahoo Finance· 12 hours agoSpanish biotech start-up, Reveal Genomics, has announced the launch of a trial evaluating the...
Team highlights long-term impact of socioeconomic inequalities on quality of life for women after ...
Medical Xpress· 8 hours agoWhen it comes to health, inequalities can be seen at every level for women with breast cancer:...
AstraZeneca's breast cancer drug combination fails in late-stage trial
Reuters via AOL· 21 hours agoTriple-negative breast cancer remains one of the most challenging forms of disease to treat due to...
Linda Perry had double mastectomy amid secret, 'stressful' breast cancer battle
USA TODAY via Yahoo News· 6 days agoLinda Perry is revealing her double mastectomy after a "stressful," secret battle with...
Mammograms should start by age 40, task force says
The Lima News, Ohio via Yahoo News· 4 hours agoJun. 18—LIMA — Women should start receiving mammograms at age 40, according to newly revised guidelines from the U.S. Preventative Task Force. The task force updated its breast</ ...
Researchers discover promising approach to prevent recurrence of breast cancer
Medical Xpress· 1 day agoAlthough treatment outcomes for breast cancer have significantly improved through new research-based therapies, it remains the second most common fatal ...
Recognizing signs of breast cancer in older women
Medical News Today· 6 days agoMost breast cancers are found in females aged 45 years or older, with the average age of diagnosis being around 62 years. Early signs of breast ...
What to do if breast cancer recurs
Rolling Out· 3 days agoBreast cancer recurrence is a challenging and frightening experience for many survivors. After going through the initial treatment and feeling the relief...
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
Zacks via Yahoo Finance· 13 hours agoAstraZeneca's (AZN) phase III CAPItello-290 study evaluating Truqap plus chemotherapy in patients...
AstraZeneca's Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial -...
Benzinga· 15 hours agoThe study did not meet the dual primary endpoints of improvement in overall survival (OS) versus...